| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.03 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | -0.35 | 0.03 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.13 | 0.03 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.03 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.082 | 0.03 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.067 | 0.03 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.03 |